ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,068.12
0.10%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
-0.01%
Brent Oil
82.275
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Verrica Parmaceuticals Inc (VRCA)

  7. Verrica Parmaceuticals Inc (VRCA) ニュース

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VRCA
日付受信時刻ニュースソース見出しコード企業名
2024/06/1105 : 18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/06/0805 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/06/0805 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/05/1520 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/05/1405 : 31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/05/1321 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
2024/05/1320 : 46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/02/2922 : 05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRCAVerrica Parmaceuticals Inc
2024/02/2921 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2024/01/0822 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1706 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1706 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1706 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1706 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1706 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1700 : 28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1606 : 54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1606 : 42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1606 : 21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1606 : 16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/1606 : 07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/0921 : 54Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
2023/11/0921 : 41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/08/2905 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/08/2905 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/08/2905 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/08/2905 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/08/0820 : 52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
2023/08/0820 : 40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
2023/07/2805 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRCA

最近閲覧した銘柄

NYSE
XOM
Exxon Mobil
NYSE
BAC
Bank of America
USI
USTECH100
US Tech 100
AMEX
XLF
Financial Select Sector
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
AXP
American Express
COIN
SOLUSD
Solana
NYSE
NKE
Nike
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有